Literature DB >> 23591712

[Implantation of Watchman™ occluder of the left atrial appendage. Tips and tricks].

Carsten W Israel1, Wladimir N Tschishow, Denio Ridjab, Stephan Kische, Julia Buddecke, Hüseyin Ince.   

Abstract

The implantation of an occluder system for the left atrial appendage (LAA) represents an interesting alternative for patients with atrial fibrillation and a CHA2DS2-VASc-Score ≥ 2 who cannot take permanent anticoagulation for various reasons. As in other left cardiac interventions, there are potentially dangerous possibilities for complications that can limit the advantages of this therapy. This overview summarizes practical tips and tricks at the implantation of a Watchman™ occluder which may help to minimize the complication rate. These hints refer to peri-interventional anticoagulation as well as transseptal puncture (technique, imaging), exchange of catheters, left atrial pressure, intubation and fluoroscopy of the LAA, preparation of the device and sheath, delivery of the Watchman™ device, confirmation of optimal position, and partial or complete recapture. If these precautions are considered, the complication rate at implantation of a Watchman™ occluder should be < 5 %, the rate of complications with long-term consequences < 1 %, and the implant success should lie > 95 %.

Entities:  

Mesh:

Year:  2013        PMID: 23591712     DOI: 10.1007/s00399-013-0259-5

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  7 in total

1.  The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.

Authors:  Juan F Viles-Gonzalez; Saibal Kar; Pamela Douglas; Srinivas Dukkipati; Ted Feldman; Rodney Horton; David Holmes; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2012-03-06       Impact factor: 24.094

2.  Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.

Authors:  Luigi Di Biase; J David Burkhardt; Prasant Mohanty; Javier Sanchez; Rodney Horton; G Joseph Gallinghouse; Dhanunjay Lakkireddy; Atul Verma; Yaariv Khaykin; Richard Hongo; Steven Hao; Salwa Beheiry; Gemma Pelargonio; Antonio Dello Russo; Michela Casella; Pietro Santarelli; Pasquale Santangeli; Paul Wang; Amin Al-Ahmad; Dimpi Patel; Sakis Themistoclakis; Aldo Bonso; Antonio Rossillo; Andrea Corrado; Antonio Raviele; Jennifer E Cummings; Robert A Schweikert; William R Lewis; Andrea Natale
Journal:  Circulation       Date:  2010-06-01       Impact factor: 29.690

3.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

4.  Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period.

Authors:  Oussama M Wazni; Salwa Beheiry; Tamer Fahmy; Conor Barrett; Steven Hao; Dimpi Patel; Luigi Di Biase; David O Martin; Mohamed Kanj; Mauricio Arruda; Jennifer Cummings; Robert Schweikert; Walid Saliba; Andrea Natale
Journal:  Circulation       Date:  2007-11-12       Impact factor: 29.690

5.  Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy.

Authors:  Ayman A Hussein; David O Martin; Walid Saliba; Deven Patel; Saima Karim; Omar Batal; Mustafa Banna; Michelle Williams-Andrews; Minerva Sherman; Mohamed Kanj; Mandeep Bhargava; Thomas Dresing; Thomas Callahan; Patrick Tchou; Luigi Di Biase; Salwa Beheiry; Bruce Lindsay; Andrea Natale; Oussama Wazni
Journal:  Heart Rhythm       Date:  2009-07-10       Impact factor: 6.343

6.  Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Authors:  Gilbert Habib; Bruno Hoen; Pilar Tornos; Franck Thuny; Bernard Prendergast; Isidre Vilacosta; Philippe Moreillon; Manuel de Jesus Antunes; Ulf Thilen; John Lekakis; Maria Lengyel; Ludwig Müller; Christoph K Naber; Petros Nihoyannopoulos; Anton Moritz; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

7.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Authors:  David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.